-
The role of the primitive marker CD133 in CD34-negative acute myeloid leukemia for the detection of leukemia stem cells
Reuvekamp, T., Janssen, L. L. G., Ngai, L. L., Carbaat-Ham, J., den Hartog, D., Scholten, W. J., Kelder, A., Hanekamp, D., Wensink, E., van Gils, N., Gradowska, P., Löwenberg, B., Ossenkoppele, G. J., van de Loosdrecht, A. A., Westers, T. M., Smit, L., Bachas, C. & Cloos, J., 23 Aug 2024, (E-pub ahead of print) In: Cytometry. Part B, Clinical cytometry.Research output: Contribution to journal › Article* › Academic › peer-review
-
Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression
van Spronsen, M. F., Hanekamp, D., Westers, T. M., van Gils, N., Vermue, E., Rutten, A., Jansen, J. H., Lissenberg-Witte, B. I., Smit, L., Schuurhuis, G. J. & van de Loosdrecht, A. A., Mar 2023, In: Leukemia. 37, 3, p. 680-690 11 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication
Hansen, Q., Bachas, C., Smit, L. & Cloos, J., 2022, In: Cancer Drug Resistance. 5, 2, p. 344-367 24 p.Research output: Contribution to journal › Review article* › Academic › peer-review
- All publications
